🇮🇳 India Daybook: HCL Tech & Nestle in Focus for Q4 Results; HG Infra Bags Railway Order

📍 Q4 RESULTS / BOARD MEETINGS

• HCL Technologies: The IT major is scheduled to report its Q4 FY26 financial results today after market hours. Investors are watching for guidance on discretionary spending and deal pipelines.
• Nestle India: The board will meet to consider audited financial results for the year ended March 31, 2026, and recommend a final dividend for the financial year.
• Persistent Systems: Board meeting scheduled today to approve quarterly financial results and consider a final dividend.
• Patanjali Foods: The company’s board is set to meet today to consider and declare a second interim dividend for FY 2025-26.
• 360 ONE WAM: Board meeting scheduled to consider financial results and an interim dividend.
• Cyient DLM: The company will review and approve its yearly financial results for the period ended March 31, 2026.

📍 ORDER WIN

• HG Infra Engineering: The company has reportedly secured a significant railway order for the Mirzapur project, boosting its infrastructure order book.
• Dredging Corporation of India: Signed a Memorandum of Understanding (MoU) worth ₹2,157 crore with IOCL for the fuel supply of its dredging fleet.
• Marsons: Secured an order or funding worth ₹15 crore from Inox Solar for renewable energy projects.
• Texmaco Rail & Engineering: Bagged a new order worth ₹3 crore from the Modern Coach Factory in Raebareli.
• Orient Green Power: Received a contract worth ₹8.6 crore for the supply of two wind turbine generators.

📍 ACQUISITION & JOINT VENTURE

• JSW Steel: The company has entered into a Joint Venture with POSCO to establish a new steel plant, aimed at expanding its specialized steel production capacity.
• Bharat Forge: Its subsidiary has signed an agreement to acquire a 90% controlling stake in RS Aero for a consideration of ₹3.6 crore.
• Tega Industries: Incorporated a new subsidiary, Tega Solutions, to further expand its global business operations.

📍 PHARMA & USFDA

• Cipla: The company received two Form 483 observations from the USFDA following a routine inspection of its Goa manufacturing facility conducted earlier this month.
• Lupin: Received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Dapagliflozin tablets, strengthening its anti-diabetic portfolio.
• Aurobindo Pharma: Secured USFDA approval for Dapagliflozin and Metformin Hydrochloride Extended-Release tablets with 180-day exclusivity.
• Zydus Lifesciences: Received USFDA approval for its oncology injectable manufacturing facility in Ahmedabad, enabling the production of specialized cancer drugs for the US market.

📍 OTHERS

• Vedanta: The company has announced May 1, 2026, as the record date for its mega demerger, where shareholders will receive shares in new entities on a 1:1 basis.
• Jio Financial Services: The company is reportedly scaling up its lending operations while maintaining a cautious stance on unsecured credit.
• TVS Motor Company: Announced its strategic entry into the Zambian market as part of its African expansion plan.
• Shyam Metalics: The Enforcement Directorate (ED) has reportedly attached investments worth ₹152 crore belonging to its arm, Eastern Coalfields, in an ongoing PMLA case.

TAGS: India Daybook, Stocks in News, Corporate News, Stock Market, Company News

Tags: India Daybook Stocks in News Corporate News Stock Market Company News